01:30 AM EDT, 08/29/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our target price of $243 (up from $186) is 17x our FY 26 (Jan.) EPS view of $14.27, above the 10-year P/E mean of 14.6x, reflecting DKS's athlete engagement and our expectations of further market share gains, and a more positive view of the approved FL deal. We note DKS deferred details of the pending deal to the FQ3 earnings call, but Foot Locker's weak FQ2 results have made the turnaround challenge seem harder vs. three months ago. The risk of the deal being less accretive due to share price changes has also grown. Still, we remain impressed by FQ2 results and we now pivot to cautiously monitoring of demand after DKS's guidance proved conservative, in line with our expectations. We think DKS athletes will prove well positioned to keep engaging and transacting even at higher price points lifting margin performance above expectations. We think this strength should offset dilution-related concerns from the pending FL closing. We revise FY 26 EPS to $14.27 from $14.34 and FY 27's to $15.37 from $15.31.